Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

QLT Inc (NASDAQ:QLTI)

1.51
Delayed Data
As of May 05
 -0.07 / -4.43%
Today’s Change
1.39
Today|||52-Week Range
3.26
-23.32%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$80.8M

Company Description

QLT, Inc. is a biotechnology company, which engages in the development and commercialization of innovative ocular products that address the unmet medical needs of patients and clinicians worldwide. It also focuses on developing synthetic retinoid program for the treatment of certain inherited retinal diseases. The company was founded by Julia G. Levy and John C. Brown on February 3, 1981 and is headquartered in Vancouver, Canada.

Contact Information

QLT, Inc.
887 Great Northern Way
Vancouver British Columbia V5T 4T5
P:(604) 707-7000
Investor Relations:

Employees

Shareholders

Mutual fund holders7.81%
Other institutional59.37%
Individual stakeholders45.77%

Top Executives

Geoffrey F. CoxChief Executive Officer & Director
Glen W. IbbottChief Financial Officer & Senior VP-Finance
Sushanta MallickVice President-Research & Development
Dori Christine AssalySecretary & Senior Vice President-Legal